Showing results (251-260 of 273) with videos related to
Sort By:
Pageof 28
Journal of Clinical Medicine|October 14, 2023
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi ConsensusFerdinando D'Amico, Virginia Solitano, Fernando Magro, et al.World Journal of Hepatology|April 14, 2015
Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3Sebastián Marciano, Silvia M Borzi, Melisa Dirchwolf, et al.Proceedings of the National Academy of Sciences of the United States of America|January 26, 2005
Host population persistence in the face of introduced vector-borne diseases: Hawaii amakihi and avian malariaBethany L Woodworth, Carter T Atkinson, Dennis A Lapointe, et al.Autoimmunity Reviews|May 11, 2021
Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensusFerdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.JTCVS Open|May 1, 2025
Gender disparities in cardiothoracic surgical conference scholarly interactions: A prime opportunity for change in cultureShanique A Ries, Emily June Zolfaghari, Adrian Higaki, et al.Leukemia|June 27, 2019
Correction: S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cellsK Vrzalikova, M Ibrahim, M Vockerodt, et al.Leukemia|September 8, 2017
S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cellsK Vrzalikova, M Ibrahim, M Vockerodt, et al.Nature Reviews. Gastroenterology & Hepatology|August 28, 2021
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel diseasePablo A Olivera, Stephane Zuily, Paulo G Kotze, et al.Autoimmunity Reviews|December 21, 2023
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness studyVirginia Solitano, Paola Facheris, Magnus Petersen, et al.Pageof 28